Top Page
Deveron UAS (FARM.H) vs. iShares MSCI Canada ETF (EWC)
Deveron UAS Business Overview & Revenue Model
Deveron UAS Financial Statement Overview
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Deveron UAS Technical Analysis
Deveron UAS Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | C$43.72M | 0.46 | 45.36% | ― | 37.95% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | C$2.86M | -2.52 | ― | ― | 33.92% | -402.25% | |
45 Neutral | C$9.73M | -3.42 | -540.25% | ― | -33.97% | 59.10% | |
42 Neutral | C$6.87M | -1.20 | -212.14% | ― | -56.02% | 91.71% | |
39 Underperform | C$5.17M | -15.43 | -3428.85% | ― | -15.33% | 47.13% |
Deveron UAS Corporate Events
Deveron Corp. shareholders have overwhelmingly approved a sweeping set of restructuring measures at a special meeting, including the sale of substantially all of the company’s assets under a share and asset purchase agreement, a corporate name change to Finis Holdings Inc., delisting its shares from the TSX Venture Exchange, applying to cease being a reporting issuer, and a voluntary winding up of the company at a time to be set by the board. The resolutions, each supported by roughly 98% of shareholders and minority shareholders, clear the way for Deveron to effectively exit the public markets and wind down its current corporate structure, with completion of the asset sale still subject to customary closing conditions and anticipated around mid-January 2026.
Deveron Corp. has issued additional disclosure at the request of Ontario Securities Commission staff regarding its proposed transaction with Aqua Capital and related matters ahead of a December 30 shareholder meeting to vote on the deal and associated resolutions. The company outlined the timeline from an initial 2024 letter of intent from Aqua Capital through the formation of a special committee in February 2025, the shift from a financing proposal to an M&A negotiation, board-level disagreements that prompted multiple director resignations, and the eventual concentration of board oversight in a single remaining director before adding one independent director. Deveron also confirmed that regulators view the amendment of its convertible debentures and the proposed transaction as connected transactions under minority protection rules, leading to the exclusion of 20,538,287 common shares, including those held by director Chris Irwin, from the minority approval calculation, a development that could influence voting dynamics and outcomes for shareholders on the proposed sale and winding-up resolutions.
Deveron Corp. has entered into an agreement to sell all its assets, including its majority stake in A&L Canada Laboratories East, Inc., to affiliates of Rock River Laboratory Inc. This decision comes as a strategic move to address liquidity issues and maturing debt. The transaction, valued at US$36.4 million, will involve a combination of cash, secured seller notes, and equity in Rock River. Aqua Capital will provide equity for the transaction and remain the controlling shareholder of Rock River. The sale is expected to help Deveron settle its outstanding debts and provide a return of capital to its shareholders, while also involving adjustments for working capital and foreign exchange fluctuations.
Deveron Corp. announced the resignation of directors Roger Dent, Greg Patterson, and Ron Patterson, while appointing Chris Irwin as a new director. Irwin, a seasoned securities and corporate law practitioner, is expected to bring valuable expertise to the company’s board. This leadership change may influence Deveron’s strategic direction and operations, potentially impacting its market positioning and stakeholder relationships.
Deveron Corp. has announced that it will not meet the deadline for filing its audited consolidated financial statements for the fiscal year ending June 30, 2025, due to financial difficulties. This delay highlights the company’s current financial challenges, which may impact its operations and stakeholder confidence.
Deveron Corp. has entered into an amended forbearance agreement with Toronto Dominion Bank concerning a $25 million loan. This amendment allows the company to continue its strategic review process to explore alternatives for addressing its short-term liquidity needs. The agreement provides temporary relief from certain defaults under the original credit agreement, potentially impacting Deveron’s operational stability and strategic positioning in the agriculture technology sector.